| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 10, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00563.2002
Submitted on July 8, 2002
Accepted on October 4, 2002
1 University of Southern California, The Heart Institute, Good Samaritan Hospital, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: ThorstenReffelmann{at}web.de.
Two independent cardioprotective interventions, Na+/H+-exchange inhibition and ischemic preconditioning (PC), were investigated with respect to differential effects on microvascular and myocardial salvage in anesthetized rabbits (30 minutes ischemia, 180 minutes reperfusion). 300 µg/kg cariporide before occlusion and PC reduced infarct size (IS, triphenyltetrazolium) (control: 46.0±4.2% of RA (risk area), cariporide: 17.6±3.7% (p<0.01), PC: 27.5±4.1% (p<0.01)), and concomitantly anatomic no-reflow (ANR, thioflavin S) (control: 40.4±3.7%, cariporide: 19.0±2.9% (p<0.01), PC: 26.9±3.4% (p<0.05)). Regional myocardial blood flow (RMBF, radioactive microspheres) in the RA, deteriorating between 30 and 180 minutes of reperfusion (control: 79±6% to 26±2% of non-ischemic flow), was shifted to higher values with both treatments (Cariporide: 110±12% to 49±7%, p<0.05, PC: 109±8% to 38±6%, p<0.05). However, neither intervention uncoupled the close relationship between IS and ANR (r=0.92-0.95) or RMBF. Cariporide given at reperfusion, did not alter IS, ANR, RMBF, or their close interrelationships. Since size and spatial distribution of no-reflow and myocardial necrosis remained closely coupled with independent cardioprotective interventions, a potential causal connection between microvascular and myocardial salvage is discussed.
This article has been cited by other articles:
|
|
 |
|
  S. L. Hale, A. Mehra, J. Leeka, and R. A. Kloner Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H421 - H425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur. Heart J., April 1, 2007; 28(7): 788 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Wilson and R. J. Diaz The myocardial no-reflow phenomenon: Role of {delta}PKC Cardiovasc Res, March 1, 2007; 73(4): 623 - 625. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kloner and S. H. Rezkalla Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J. Am. Coll. Cardiol., July 21, 2004; 44(2): 276 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Reffemann and R. A. Kloner Microvascular Alterations After Temporary Coronary Artery Occlusion: The No-Reflow Phenomenon Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 163 - 172. [Abstract] [PDF]
|
|
|
|
|
|
R. A. Kloner and W. Dai Glycoprotein IIb/IIIa inhibitors and no-reflow J. Am. Coll. Cardiol., January 21, 2004; 43(2): 284 - 286. [Full Text] [PDF]
|
|
|
|
|
|
T. Reffelmann and R. A Kloner Cardiovascular effects of sildenafil in experimental ischemia-reperfusion (reply to "Sildenafil-induced cardioprotection in rabbits, by Kukreja, R.C., Ockaili, R., Salloum, F., Xi, L.") Cardiovasc Res, December 1, 2003; 60(3): 702 - 703. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
